Clark Eliana sold NTLA
January 5, 2026 · Form 4 insider transaction
Clark Eliana sold 9,515 shares of Intellia Therapeutics, Inc. at $9.21 per share, a transaction worth $87.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
9,515
Price
$9.21
Total value
$87.6K
InsiderClark Eliana
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 5, 2026
Filing dateJanuary 7, 2026
Shares owned after87,118
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.; Includes 1,264 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on December 31, 2025.